Baxter has launched the new Welch Allyn Connex 360 Vital Signs Monitor, designed to streamline patient monitoring and clinical documentation.
The device captures key vital signs for adult, pediatric, and neonatal patients, including blood pressure, temperature, pulse rate, respiration rate, and oxygen saturation. Baxter noted that care teams can record a complete set of vitals in under a minute and seamlessly upload the data to electronic medical records (EMRs), reducing manual entry errors.
“There is nothing more important than keeping patients safe, especially when time is of the essence,” said Julie Foster, President of Front Line Care at Baxter. “Care teams rely on vital signs monitoring to help detect changes in their patients’ conditions and make informed decisions. With Connex 360, we are advancing patient monitoring to provide care teams with the timely insights they need at the bedside, so they can make the most of every moment with their patients.”
The Connex 360 integrates with Baxter’s DeviceBridge cloud platform to securely transfer patient data to hospital IT systems, enhancing interoperability across connected devices.
Equipped with end-to-end encryption, a large touchscreen, customizable early warning protocols, and software upgrade support for clinical and cybersecurity updates, the monitor aims to enhance real-time decision-making at the point of care.
Baxter entered the patient monitoring space through its $12.5 billion acquisition of Hillrom and the Welch Allyn portfolio in 2021. The new device has received U.S. Food and Drug Administration (FDA) 510(k) clearance and is now available to hospitals and health systems across the U.S.